Orphelia Pharma

Orphelia Pharma Overview

Founded 2007
Founded
Status Private
Employees 3
Employees
Latest Deal Type Accelerator/​Inc
Investors 2

Orphelia Pharma General Information

Description

Developer of pediatric medicines created to improving the health and well-being of severely disabled children. The company's Pediatric medicines development platform is developing new medicinal products to the market in niche indications where the medical need is the most salient: in neuro-pediatry (epilepsy, neuro-degenerative diseases) and in metabolic diseases, enabling sick children and their families to improve health and quality of life.

Contact Information

Formerly Known As
TargeOn
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 65 rue Rambuteau
  • 75004 Paris
  • France
+33 01 00 00 00 00
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Orphelia Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 01-Jan-2015 Completed Generating Revenue
1. Corporate 01-Jan-2007 Completed Startup

Orphelia Pharma Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Axial Biotherapeutics Venture Capital-Backed Waltham, MA 00 0000 0000000000 0 0000
000000000 Formerly VC-backed Nimes, France 00 000.00 00000000 000.00
000000000 Formerly VC-backed San Diego, CA 000 00000 00000000000 00000

Orphelia Pharma Executive Team (3)

Name Title Board Seat Contact Info
Hugues Bienaymé Ph.D Founder, Chief Executive Officer, Chief Scientific Officer and Board Member
Pierre Attali MD Chief Medical Officer (acting)

1 Former Executive

Orphelia Pharma Board Members (2)

To view Orphelia Pharma‘s full board member team, request access »
Name Representing Role Since
Gilles Alberici Ph.D OCTALFA Chairman 000 0000

1 Former Board Member

Orphelia Pharma Investors (2)

To view Orphelia Pharma‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
OCTALFA Venture Capital Minority 000 0000 000000 0
Laboratoires Pierre Fabre Corporation Minority 000 0000 000000 0

Ready to get started?

Request a free trial